Correction to: Wizemann V, Rutkowski B, Baldamus C, et al. Comparison of the therapeutic effects of epoetin zeta to epoetin alfa in the maintenance phase of renal anaemia treatment. Curr Med Res Opin 2008; 24(3): 625–37, doi:10.1185/03007990 8X273264.
The authors have reported a second set of minor corrections to this article (in addition to the correction to Figure 2 noted in an earlier Erratum [published in Curr Med Res Opin 2008;24(4):1155; doi:10.1185/030079908X292010].
Figure 1 contained an error in the number of patients in the safety population assigned to the epoetin alfa arm: n = 155. The correct number is 158. The numbers are reported correctly in the abstract and main text; Results and Conclusions of the study are not affected by this error.
On page 633 [right-hand column, line 26] there was an error in the percentage and number of adverse events judged as ‘not related’ or ‘unlikely to be related’ to the study drug: 94.9% (n = 860). The corrected numbers are 99.4% [n = 901]. Study conclusions are not affected by this error.